50 results on '"Grant, Peter J."'
Search Results
2. Guideline recommendations and the positioning of newer drugs in type 2 diabetes care
3. Transglutaminase 2 limits the extravasation and the resultant myocardial fibrosis associated with factor XIII-A deficiency
4. Guanidino compound ratios are associated with stroke etiology, internal carotid artery stenosis and CHA2DS2-VASc score in three cross-sectional studies
5. An evaluation of 20 year survival in patients with diabetes mellitus and acute myocardial infarction
6. (±) cis-bisamido epoxides: A novel series of potent FXIII-A inhibitors
7. Normal Bone Deposition Occurs in Mice Deficient in Factor XIII-A and Transglutaminase 2
8. Chapter 8 - Hemostatic abnormalities associated with diabetes and their clinical implications
9. Diabetes is associated with posttranslational modifications in plasminogen resulting in reduced plasmin generation and enzyme-specific activity
10. The activation peptide cleft exposed by thrombin cleavage of FXIII-A2 contains a recognition site for the fibrinogen α chain
11. Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulation
12. Proteolytic and genetic variation of the alpha-2-antiplasmin C-terminus in myocardial infarction
13. Interactions between factor XIII and the αC region of fibrinogen
14. Effect of transglutaminase 2 (TG2) deficiency on atherosclerotic plaque stability in the apolipoprotein E deficient mouse
15. Association of coagulation factor XIII-A with Golgi proteins within monocyte-macrophages: implications for subcellular trafficking and secretion
16. Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke
17. Complement C3 and C-reactive protein in male survivors of myocardial infarction
18. Nanoscale Probing Reveals that Reduced Stiffness of Clots from Fibrinogen Lacking 42 N-Terminal B β-Chain Residues Is Due to the Formation of Abnormal Oligomers
19. Common variation in the C-terminal region of the fibrinogen β-chain: effects on fibrin structure, fibrinolysis and clot rigidity
20. β 3 integrin haplotype influences gene regulation and plasma von Willebrand factor activity
21. Functional analysis of fibrin γ-chain cross-linking by activated factor XIII: determination of a cross-linking pattern that maximizes clot stiffness
22. Coagulation and atherothrombotic disease
23. List of contributors
24. Guía de práctica clínica de la ESC sobre diabetes, prediabetes y enfermedad cardiovascular, en colaboración con la European Association for the Study of Diabetes
25. The molecular physiology and pathology of fibrin structure/function
26. The Human Hydroxyacylglutathione Hydrolase (HAGH) Gene Encodes Both Cytosolic and Mitochondrial Forms of Glyoxalase II
27. Genetics of fibrin clot structure: a twin study
28. Roles of Low Specificity and Cofactor Interaction Sites on Thrombin during Factor XIII Activation: COMPETITION FOR COFACTOR SITES ON THROMBIN DETERMINES ITS FATE
29. Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk
30. Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms
31. Activation markers of coagulation and fibrinolysis in twins: heritability of the prethrombotic state
32. Increased fibrinogen, von Willebrand factor and tissue plasminogen activator levels in insulin resistant South Asian patients with ischaemic stroke
33. The genetics of haemostasis: a twin study
34. Impaired fibrinolysis and increased fibrinogen levels in South Asian subjects
35. Genetics of coronary heart disease: Current knowledge and research principles
36. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure
37. α-Fibrinogen Thr312Ala polymorphism and venous thromboembolism
38. Positioning newer drugs in the management of type 2 diabetes
39. Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease
40. Genetic determinants of arterial thrombosis
41. Association of a Common Polymorphism in the Factor XIII Gene With Venous Thrombosis
42. Chapter 54 - Common Genetic Determinants of Coagulation and Fibrinolysis
43. Activation of coagulation and fibrinolytic system and thrombotic tendency
44. Relationship between FXIIIV34L and Factor V Leiden in patients with venous thrombosis
45. Factor V Leiden and prothrombin 20210A mutation in patients with inflammatory bowel disease
46. The effect of short-term exercise on plasma procoagulant activity in patients with type II (non-insulin-dependent) diabetes and healthy volunteers
47. The Effect of Number of Days in Culture and Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G Genotype on PAI-1 Antigen Release by Cultured Human Umbilical Vein Endothelial Cells
48. Motivation and glycemic control in diabetes mellitus
49. The UK Prospective Diabetes study
50. Platelet glycoprotein IIIa PI A polymorphism in young men with myocardial infarction
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.